Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD
OPEN Gut | 6 Feb 2016
T Lee, T Clavel, K Smirnov, A Schmidt, I Lagkouvardos, A Walker, M Lucio, B Michalke, P Schmitt-Kopplin, R Fedorak and D Haller
Iron deficiency is a common complication in patients with IBD and oral iron therapy is suggested to exacerbate IBD symptoms. We performed an open-labelled clinical trial to compare the effects of per oral (PO) versus intravenous (IV) iron replacement therapy (IRT).
* Data courtesy of Altmetric.com